Cargando…

APR-246/PRIMA-1(MET) inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase

Detalles Bibliográficos
Autores principales:	Peng, Xiaoxiao, Zhang, Mei-Qiong-Zi, Conserva, Francesca, Hosny, Gihan, Selivanova, Galina, Bykov, Vladimir JN, Arnér, Elias SJ, Wiman, Klas G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477569/ https://www.ncbi.nlm.nih.gov/pubmed/28406483 http://dx.doi.org/10.1038/cddis.2016.137

Ejemplares similares

APR-246/PRIMA-1(MET) inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
por: Peng, X, et al.
Publicado: (2013)

Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246
por: Haffo, Lena, et al.
Publicado: (2018)

APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2018)

Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2019)

The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells
por: Synnott, Naoise C., et al.
Publicado: (2018)

Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy
por: Bykov, Vladimir J. N., et al.
Publicado: (2016)

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
por: Mohell, N, et al.
Publicado: (2015)

Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma
por: Aryee, D N T, et al.
Publicado: (2013)

Antitumor Effects of PRIMA-1 and PRIMA-1(Met) (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
por: Menichini, Paola, et al.
Publicado: (2021)

Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1(MET)/APR-246
por: Aberdam, Edith, et al.
Publicado: (2020)

PRIMA-1(MET) Inhibits Growth of Mouse Tumors Carrying Mutant p53
por: Zache, Nicole, et al.
Publicado: (2008)

PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation
por: Yin, Zhi-Xian, et al.
Publicado: (2017)

Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone
por: Shu, Nan, et al.
Publicado: (2019)

Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2021)

A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
por: Ceder, Sophia, et al.
Publicado: (2020)

PRIMA-1 and PRIMA-1(Met) (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
por: Perdrix, Anne, et al.
Publicado: (2017)

Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2022)

Overexpression of chloroplast NADPH-dependent thioredoxin reductase in Arabidopsis enhances leaf growth and elucidates in vivo function of reductase and thioredoxin domains
por: Toivola, Jouni, et al.
Publicado: (2013)

Stress defense mechanisms of NADPH-dependent thioredoxin reductases (NTRs) in plants
por: Cha, Joon-Yung, et al.
Publicado: (2015)

Calredoxin regulates the chloroplast NADPH-dependent thioredoxin reductase in Chlamydomonas reinhardtii
por: Zinzius, Karen, et al.
Publicado: (2023)

PRIMA-1(met) (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms
por: Li, Xiao-Lan, et al.
Publicado: (2015)

Synergistic effects of PRIMA-1(Met) (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
por: Maslah, Nabih, et al.
Publicado: (2020)

Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246
por: Zhou, Xiaolei, et al.
Publicado: (2022)

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
por: Fransson, Åsa, et al.
Publicado: (2016)

Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase
por: Prigge, Justin R., et al.
Publicado: (2017)

Cytosolic thioredoxin reductase 1 is required for correct disulfide formation in the ER
por: Poet, Greg J, et al.
Publicado: (2017)

Structure of Hordeum vulgare NADPH-dependent thioredoxin reductase 2. Unwinding the reaction mechanism
por: Kirkensgaard, Kristine G., et al.
Publicado: (2009)

Thioredoxin reductase from Bacillus cereus exhibits distinct reduction and NADPH‐binding properties
por: Shoor, Marita, et al.
Publicado: (2021)

Comparative Molecular Modeling Study of Arabidopsis NADPH-Dependent Thioredoxin Reductase and Its Hybrid Protein
por: Lee, Yuno, et al.
Publicado: (2012)

Multilevel regulation of non‐photochemical quenching and state transitions by chloroplast NADPH‐dependent thioredoxin reductase
por: Nikkanen, Lauri, et al.
Publicado: (2019)

Molecular Basis for the Interactions of Human Thioredoxins with Their Respective Reductases
por: Hossain, Md Faruq, et al.
Publicado: (2021)

Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness
por: Peng, Xiaoxiao, et al.
Publicado: (2016)

Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
por: Kaminska, Kamila K., et al.
Publicado: (2016)

Crystal Structure of the Apo-Form of NADPH-Dependent Thioredoxin Reductase from a Methane-Producing Archaeon
por: Buey, Rubén M., et al.
Publicado: (2018)

Insights into the function of NADPH thioredoxin reductase C (NTRC) based on identification of NTRC-interacting proteins in vivo
por: González, Maricruz, et al.
Publicado: (2019)

APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
por: Xie, Xuqin, et al.
Publicado: (2023)

Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures
por: Dammeyer, Pascal, et al.
Publicado: (2014)

Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells
por: Anestål, Karin, et al.
Publicado: (2008)

The contribution of NADPH thioredoxin reductase C (NTRC) and sulfiredoxin to 2-Cys peroxiredoxin overoxidation in Arabidopsis thaliana chloroplasts
por: Puerto-Galán, Leonor, et al.
Publicado: (2015)

NADPH-Thioredoxin Reductase C Mediates the Response to Oxidative Stress and Thermotolerance in the Cyanobacterium Anabaena sp. PCC7120
por: Sánchez-Riego, Ana M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_80ev0n12u6v19892jph8fk02hl